High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Emory University
Emory University
University of Washington
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Hangzhou Cancer Hospital
UNC Lineberger Comprehensive Cancer Center
IFOM ETS - The AIRC Institute of Molecular Oncology
Hospices Civils de Lyon
Tanta University
Qingdao Sino-Cell Biomedicine Co., Ltd.
Sun Yat-sen University
Peking University Third Hospital
Changhai Hospital
University of Alberta
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Vanderbilt University Medical Center
University of Kentucky
Chengdu University of Traditional Chinese Medicine
University of Nebraska
Tosk, Inc.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University Hospital Southampton NHS Foundation Trust
Syndax Pharmaceuticals
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Yale University
Children's Oncology Group
Yonsei University
Memorial Sloan Kettering Cancer Center
Yonsei University
Wake Forest University Health Sciences
Yonsei University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
University of Washington
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Eastern Hepatobiliary Surgery Hospital
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Betta Pharmaceuticals Co., Ltd.
Steba Biotech S.A.
Columbia University
University of Rochester
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
STEBA France
Aposense Ltd.
French Innovative Leukemia Organisation